Hospital Cost Statistics (2026)

There were 32.9 million inpatient hospital stays in the US in 2022, and they cost $548.5 billion to deliver.

Dividing one by the other gives about $16,675 per stay, which is our arithmetic rather than a published average and is worth treating as an order of magnitude rather than a typical bill.

Hospital care is the largest single component of US health spending, roughly 31.2% of the national total in 2023, which is why this dataset governs so much of the wider cost picture.

AHRQ states the caveat in its own introduction: hospital costs here represent the hospital's cost to produce the services, not the amount paid for services by payers.

They also exclude separately billed physician fees associated with the hospitalisation, which for many stays is a substantial additional amount arriving as a separate bill.

So $16,675 is not a hospital bill, not an insurer's payment and not a patient's liability. It is what the care cost the hospital to provide, and every other number in the chain sits above or below it for different reasons.

Septicemia cost $60.0 billion in 2022, 10.9% of all inpatient hospital cost in the country, across 2.42 million stays.

The next most expensive condition, liveborn infants, was $19.6 billion. Nothing else exceeds $19 billion.

AHRQ notes septicemia is the most costly condition for all four expected payer groups, which no other condition manages, making it the one genuinely universal driver of hospital cost.

Liveborn infants accounted for 3.49 million stays, 10.6% of all hospital stays in the US, and $19.6 billion of cost.

It is the most common reason for a hospital stay by a wide margin and only the second most expensive in aggregate, because the average newborn stay is short and uncomplicated.

AHRQ also notes that conditions related to pregnancy and childbirth accounted for four of the top 20 most expensive conditions where Medicaid was the expected payer, which is a structural feature of who Medicaid covers.

The 20 most expensive conditions accounted for $256.7 billion, 46.8% of aggregate hospital cost, across 43.1% of all stays.

That is less concentrated than the usual framing suggests. More than half of hospital spending sits outside the top 20 diagnoses entirely.

It is also why targeting a handful of conditions cannot move national hospital spending much on its own: the long tail is the majority of it.

Medicare and Medicaid together were the expected payer for 67.3% of aggregate hospital costs and 63.8% of stays.

Private insurance was the expected payer for 25.8% of costs, and self-pay or no charge for 3.3%.

Public programmes carry a larger share of cost than of stays, which follows from Medicare covering an older population whose stays are longer and more complex.

Circulatory system conditions dominate the top 20 where Medicare, private insurance or self-pay is the expected payer.

Pregnancy and childbirth conditions occupy four of the top 20 where Medicaid is the payer.

The practical reading is that the American hospital is doing structurally different work depending on who is expected to pay for it, and national averages blend those into a picture matching none of them.

The cost of a stay depends on its length, its complications and its intensity, none of which is known at admission.

Physician fees arrive separately from the hospital's own bill, which is why patients frequently receive several bills for one episode and cannot reconcile them against a single estimate.

That is the specific gap the good faith estimate rules address for uninsured and self-pay patients, and it is why requesting one in writing before scheduled care is worth the effort.

For an insured household, the relevant figure is not the hospital's cost or its charge but the plan's annual out-of-pocket limit.

That converts a $16,675 average and a long right tail into a known ceiling, which is the only version of this risk a household can plan against.

It is also the plan feature that varies most between policies with similar premiums, which makes it the number worth comparing at open enrolment.

A hospital stay is the archetypal large, unscheduled, non-deferrable expense, and it frequently arrives alongside lost income from being unable to work.

Sizing a cash reserve against the plan's out-of-pocket maximum rather than against a guess at medical costs is the version of this that is actually calculable.

For anyone on a high-deductible plan, an HSA is the account built for exactly this shape of expense, and it is the only one untaxed at every stage for qualified medical costs.

The brief uses the 2022 HCUP National Inpatient Sample, covering nonfederal acute care hospitals, so federal facilities including the VA are outside it.

Charges were converted to costs using HCUP cost-to-charge ratios, and conditions are grouped using the Clinical Classifications Software Refined categories for the principal diagnosis.

Expected payer was missing for 0.15% of records, and because the sample is large enough that small differences are statistically significant, AHRQ discusses only differences greater than 10%.

Every figure is from AHRQ Healthcare Cost and Utilization Project Statistical Brief #316, National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2022, published February 2026, table 1 and the accompanying payer analysis.

The average cost per stay is our arithmetic on the published totals, labelled as such rather than presented as an AHRQ figure.

The 31.2% share of national health spending is cited within the brief from the National Health Expenditure Accounts for 2023.